Fidelity Disruptive Medicine ETF Rating $24.75 0.00 (0.00%) As of 05/22/2026 03:58 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy 2.76Holdings in FMED have an aggregate rating of Moderate Buy based on 429 analyst ratings issued in the past year covering 22 companies (51.4% of the portfolio).FMED Aggregate Price Target$24.75High Prediction$24.75Average Prediction$24.75Low Prediction$24.75Holdings in FMED have an aggregate price target of $24.75 and a range of $24.75 to $24.75 covering 22 companies (51.4% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy4 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 FMED Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.29%LFSTLifeStance Health Group$7.393.7246 of 5 stars3.00$9.86 33.4%10Analyst Upgrade3.30%DHRDanaher$172.12+0.1%4.7538 of 5 stars2.86$238.65 38.7%22Positive News3.25%ISRGIntuitive Surgical$438.104.184 of 5 stars2.67$579.33 32.2%27Positive NewsAnalyst Downgrade2.85%ALNYAlnylam Pharmaceuticals$297.454.7134 of 5 stars2.85$463.13 55.7%26Positive News2.75%COGTCogent Biosciences$32.672.3182 of 5 stars2.86$43.73 33.8%142.62%ARGXargenex$806.464.3247 of 5 stars2.92$1,017.78 26.2%242.49%UNHUnitedHealth Group$388.420.0%4.0813 of 5 stars2.74$387.57 -0.2%27Positive NewsAnalyst Forecast2.45%LEGNLegend Biotech$29.374.2094 of 5 stars2.67$59.00 100.9%15Gap Down2.34%TXG10x Genomics$23.681.4558 of 5 stars2.20$23.17 -2.2%15Gap Up2.31%MRNAModerna$46.881.2866 of 5 stars1.84$35.73 -23.8%19Insider Trade2.23%ASNDAscendis Pharma A/S$247.053.5406 of 5 stars3.00$295.39 19.6%192.16%EWEdwards Lifesciences$85.93+0.2%3.1779 of 5 stars2.79$95.65 11.3%28Gap Down2.07%TECHBio-Techne$48.213.452 of 5 stars2.79$65.92 36.7%141.93%INSMInsmed$106.243.503 of 5 stars2.96$210.95 98.6%25Positive NewsInsider TradeGap Up1.93%KYMRKymera Therapeutics$78.892.5826 of 5 stars2.95$118.10 49.7%221.91%XENEXenon Pharmaceuticals$54.173.6115 of 5 stars3.00$77.07 42.3%171.80%VEEVVeeva Systems$160.40+0.1%4.8246 of 5 stars2.58$276.52 72.4%261.79%BSXBoston Scientific$57.71-0.1%4.7576 of 5 stars2.93$92.71 60.6%27Buyback Announcement1.79%PCVXVaxcyte$47.302.7873 of 5 stars2.63$86.00 81.8%81.75%PRVAPrivia Health Group$22.794.1381 of 5 stars2.79$31.23 37.0%141.71%RVMDRevolution Medicines$151.562.6504 of 5 stars3.00$111.35 -26.5%21Positive News1.68%HTFLHeartflow$29.493.337 of 5 stars2.56$37.00 25.5%9 This page (NASDAQ:FMED) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
